Tag:
Joseph DeVivo
Latest Headlines
Latest Headlines
AngioDynamics sees net income fall in Q1
AngioDynamics' ( $ANGO ) new CEO Joseph DeVivo is upbeat about his company's future even as its net income during the first quarter came in at $1.4 million, down from $1.9 million a year ago. The
AngioDynamics taps DeVivo as CEO
The board of AngioDynamics ( $ANGO ) has named Joseph DeVivo, who was most recently global president of Smith & Nephew Orthopedics, as the company's president and CEO, effective Sept. 7. DeVivo
